Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.4.0.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Assets    
Financing receivables $ 818,789 $ 783,967
Financing receivables held-for-sale 42,041 60,376
Investments available-for-sale 36,733 29,017
Real estate 131,695 128,769
Real estate related intangible assets 31,032 26,930
Equity method investments in affiliates 304,180 318,769
Cash and cash equivalents 26,585 42,645
Other assets 85,922 79,148
Total Assets 1,476,977 1,469,621
Liabilities:    
Accounts payable, accrued expenses and other 22,899 17,875
Deferred funding obligations 62,541 108,499
Credit facility 321,944 247,350
Asset-backed nonrecourse debt (secured by assets of $701 million and $718 million, respectively) 551,691 563,189
Other nonrecourse debt (secured by financing receivables of $91 million and $97 million, respectively) 94,231 100,602
Total Liabilities $ 1,053,306 $ 1,037,515
Stockholders' Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 37,030,467 and 37,010,603 shares issued and outstanding, respectively $ 370 $ 370
Additional paid in capital 485,756 482,431
Retained deficit (61,202) (52,701)
Accumulated other comprehensive loss (5,091) (1,905)
Non-controlling interest 3,838 3,911
Total Stockholders' Equity 423,671 432,106
Total Liabilities and Stockholders' Equity $ 1,476,977 $ 1,469,621